These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature. Brunelli M; Manfrin E; Miller K; Eccher A; Gobbo S; Reghellin D; Chilosi M; Remo A; Martignoni G; Menestrina F; Bonetti F J Cutan Pathol; 2009 Jun; 36(6):702-5. PubMed ID: 19515052 [TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid biochemical markers of central nervous system metastases. Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647 [TBL] [Abstract][Full Text] [Related]
25. [Telomerase activity in infiltration ductal carcinoma of breast]. Wu S; Liu Z; Sun H Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):515-6. PubMed ID: 10923461 [TBL] [Abstract][Full Text] [Related]
26. Luminal B breast tumors are not HER2 positive. Bhargava R; Dabbs DJ Breast Cancer Res; 2008; 10(5):404; author reply 405. PubMed ID: 18831725 [No Abstract] [Full Text] [Related]
27. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Quenneville LA; Phillips KA; Ozcelik H; Parkes RK; Knight JA; Goodwin PJ; Andrulis IL; O'Malley FP Cancer; 2002 Nov; 95(10):2068-75. PubMed ID: 12412159 [TBL] [Abstract][Full Text] [Related]
28. [Immunochemical changes in the cerebrospinal fluid in central nervous system tumors]. Hrazdira CL; Hrazdirová V; Polcáková M Cesk Neurol Neurochir; 1987 Jul; 50(4):238-44. PubMed ID: 2444353 [No Abstract] [Full Text] [Related]
29. Lumbar puncture in infants and young children. Menachof LW J Fam Pract; 1977 Feb; 4(2):369-72. PubMed ID: 839176 [TBL] [Abstract][Full Text] [Related]
30. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Yoder BJ; Wilkinson EJ; Massoll NA Breast J; 2007; 13(2):172-9. PubMed ID: 17319859 [TBL] [Abstract][Full Text] [Related]
31. [Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis associated to papilloedema]. Monge-Galindo L; López-Pisón J; Gracia-Torralba L; García-Iñiguez JP; Velasco-Manrique M; Peña-Segura JL Rev Neurol; 2011 Jun; 52(12):767-8. PubMed ID: 21594863 [No Abstract] [Full Text] [Related]
32. [Chemoluminescence of the cerebrospinal fluid in spinal cord tumors]. Okladnikov GI; Kamenskaia VV; Sologubova TI; Kurov OM; Belykh VB Zh Vopr Neirokhir Im N N Burdenko; 1989; (4):19-23. PubMed ID: 2816191 [TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of breast cancer: toward the individualization of therapy. Chang JC; Hilsenbeck SG; Fuqua SA Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041 [No Abstract] [Full Text] [Related]
34. Evaluation of ADVIA 120 CSF assay (Bayer) vs. chamber counting of cerebrospinal fluid specimens. Mahieu S; Vertessen F; Van der Planken M Clin Lab Haematol; 2004 Jun; 26(3):195-9. PubMed ID: 15163317 [TBL] [Abstract][Full Text] [Related]
35. Cytologic evaluation of cerebrospinal fluid with clinical and histologic correlation. Wertlake PT; Markovits BA; Stellar S Acta Cytol; 1972; 16(3):224-39. PubMed ID: 4112679 [No Abstract] [Full Text] [Related]
36. [Cytological picture of the cerebrospinal fluid in accidental hemorrhage after lumbar puncture]. Osuch Z Ann Acad Med Stetin; 1982; 28():285-97. PubMed ID: 7168502 [No Abstract] [Full Text] [Related]
37. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression. Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182 [TBL] [Abstract][Full Text] [Related]